Associations - HIF1A overexpression

BIOMARKER:

HIF1A overexpression

Entrez ID:

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

HIF1A overexpression HIF1A overexpression	HER2 Negative Breast Cancer HER2 Negative Breast Cancer	albumin-bound paclitaxel Sensitive: B - Late Trials ESMO-BC 2021 - 1 week albumin-bound paclitaxel Sensitive : B ESMO-BC 2021 - 1wk
HIF1A overexpression HIF1A overexpression	Acute Myelogenous Leukemia AML	azacitidine Sensitive: C3 – Early Trials azacitidine Sensitive : C3
HIF1A overexpression HIF1A overexpression	Myelodysplastic Syndrome MDS	azacitidine Sensitive: C3 – Early Trials azacitidine Sensitive : C3
HIF1A overexpression HIF1A overexpression	Non Small Cell Lung Cancer NSCLC	EGFR inhibitor Resistant: D – Preclinical EGFR inhibitor Resistant : D
HIF1A overexpression HIF1A overexpression	Ovarian Cancer Ovarian Cancer	CB-839 Sensitive: D – Preclinical CB-839 Sensitive : D
HIF1A overexpression HIF1A overexpression	Ovarian Cancer Ovarian Cancer	olaparib + CB-839 Sensitive: D – Preclinical olaparib + CB-839 Sensitive : D